Monday, 20 January 2020

AMTH co-leads $10M series B funding for SonoMotion

13 November 2019 | News

The funds raised will fund a pivotal study of Break Wave(TM), SonoMotion's ultrasound solution

image credit- pymnts.com

image credit- pymnts.com

Advanced MedTech Holdings (AMTH), Southeast Asia's largest medical device business headquartered in Singapore, has announced that it has co-led a $10 million Series B funding in SonoMotion, a US-based medical device startup, together with its existing investors MedVenture Partners, Inc and BioVentures Investors, to support its development of non-invasive solutions for kidney stones.

The funds raised will fund a pivotal study of Break Wave(TM), SonoMotion's ultrasound solution that fragments kidney stones non-invasively. SonoMotion also plans to launch Stone Clear(TM), a non-invasive ultrasound-based tool to reposition kidney stones within the kidney and ureter, in 2020.

Both technologies aim to bring greater convenience and comfort for patients and physicians, offering new alternatives in stone management that potentially remove the need for anesthesia or ionizing radiation.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is 2020 demanding timely action of technology adoption in healthcare?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls